Logo image of JCI

JOHNSON CONTROLS INTERNATION (JCI) Stock Fundamental Analysis

NYSE:JCI - New York Stock Exchange, Inc. - IE00BY7QL619 - Common Stock - Currency: USD

106.48  0 (0%)

After market: 106.48 0 (0%)

Fundamental Rating

4

Taking everything into account, JCI scores 4 out of 10 in our fundamental rating. JCI was compared to 41 industry peers in the Building Products industry. JCI has a medium profitability rating, but doesn't score so well on its financial health evaluation. JCI is valied quite expensively at the moment, while it does show a decent growth rate. Finally JCI also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year JCI was profitable.
JCI had a positive operating cash flow in the past year.
In the past 5 years JCI has always been profitable.
JCI had a positive operating cash flow in each of the past 5 years.
JCI Yearly Net Income VS EBIT VS OCF VS FCFJCI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B

1.2 Ratios

JCI has a Return On Assets (5.91%) which is in line with its industry peers.
With a Return On Equity value of 15.85%, JCI perfoms like the industry average, outperforming 58.54% of the companies in the same industry.
JCI's Return On Invested Capital of 7.89% is on the low side compared to the rest of the industry. JCI is outperformed by 63.41% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for JCI is significantly below the industry average of 12.83%.
The last Return On Invested Capital (7.89%) for JCI is above the 3 year average (6.34%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 5.91%
ROE 15.85%
ROIC 7.89%
ROA(3y)4%
ROA(5y)3.49%
ROE(3y)10.39%
ROE(5y)8.82%
ROIC(3y)6.34%
ROIC(5y)6%
JCI Yearly ROA, ROE, ROICJCI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

1.3 Margins

JCI's Profit Margin of 11.78% is fine compared to the rest of the industry. JCI outperforms 63.41% of its industry peers.
In the last couple of years the Profit Margin of JCI has declined.
The Operating Margin of JCI (14.94%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of JCI has grown nicely.
The Gross Margin of JCI (37.15%) is better than 60.98% of its industry peers.
JCI's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 14.94%
PM (TTM) 11.78%
GM 37.15%
OM growth 3Y-3.83%
OM growth 5Y11.73%
PM growth 3Y2.41%
PM growth 5Y-20.69%
GM growth 3Y1.1%
GM growth 5Y1.86%
JCI Yearly Profit, Operating, Gross MarginsJCI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

3

2. Health

2.1 Basic Checks

JCI has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for JCI has been reduced compared to 1 year ago.
JCI has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, JCI has a worse debt to assets ratio.
JCI Yearly Shares OutstandingJCI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
JCI Yearly Total Debt VS Total AssetsJCI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

JCI has an Altman-Z score of 2.34. This is not the best score and indicates that JCI is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.34, JCI is doing worse than 80.49% of the companies in the same industry.
The Debt to FCF ratio of JCI is 3.43, which is a good value as it means it would take JCI, 3.43 years of fcf income to pay off all of its debts.
JCI has a Debt to FCF ratio of 3.43. This is in the better half of the industry: JCI outperforms 60.98% of its industry peers.
A Debt/Equity ratio of 0.60 indicates that JCI is somewhat dependend on debt financing.
JCI has a Debt to Equity ratio (0.60) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF 3.43
Altman-Z 2.34
ROIC/WACC1.11
WACC7.08%
JCI Yearly LT Debt VS Equity VS FCFJCI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.3 Liquidity

A Current Ratio of 0.96 indicates that JCI may have some problems paying its short term obligations.
JCI has a worse Current ratio (0.96) than 92.68% of its industry peers.
A Quick Ratio of 0.81 indicates that JCI may have some problems paying its short term obligations.
The Quick ratio of JCI (0.81) is worse than 78.05% of its industry peers.
Industry RankSector Rank
Current Ratio 0.96
Quick Ratio 0.81
JCI Yearly Current Assets VS Current LiabilitesJCI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

4

3. Growth

3.1 Past

JCI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.91%, which is quite good.
Measured over the past years, JCI shows a quite strong growth in Earnings Per Share. The EPS has been growing by 13.04% on average per year.
Looking at the last year, JCI shows a very negative growth in Revenue. The Revenue has decreased by -14.34% in the last year.
The Revenue has been decreasing by -0.86% on average over the past years.
EPS 1Y (TTM)8.91%
EPS 3Y11.73%
EPS 5Y13.04%
EPS Q2Q%-7.89%
Revenue 1Y (TTM)-14.34%
Revenue growth 3Y-1.02%
Revenue growth 5Y-0.86%
Sales Q2Q%-16.3%

3.2 Future

JCI is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.04% yearly.
Based on estimates for the next years, JCI will show a small growth in Revenue. The Revenue will grow by 2.66% on average per year.
EPS Next Y0.01%
EPS Next 2Y7.94%
EPS Next 3Y10.61%
EPS Next 5Y11.04%
Revenue Next Year-11.84%
Revenue Next 2Y-3.8%
Revenue Next 3Y-1.07%
Revenue Next 5Y2.66%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
JCI Yearly Revenue VS EstimatesJCI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10B 20B 30B
JCI Yearly EPS VS EstimatesJCI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

2

4. Valuation

4.1 Price/Earnings Ratio

JCI is valuated quite expensively with a Price/Earnings ratio of 28.09.
JCI's Price/Earnings ratio is a bit more expensive when compared to the industry. JCI is more expensive than 70.73% of the companies in the same industry.
JCI's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.24.
A Price/Forward Earnings ratio of 24.63 indicates a rather expensive valuation of JCI.
Compared to the rest of the industry, the Price/Forward Earnings ratio of JCI indicates a slightly more expensive valuation: JCI is more expensive than 65.85% of the companies listed in the same industry.
JCI's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 36.42.
Industry RankSector Rank
PE 28.09
Fwd PE 24.63
JCI Price Earnings VS Forward Price EarningsJCI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, JCI is valued a bit more expensive than the industry average as 68.29% of the companies are valued more cheaply.
JCI's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 24.07
EV/EBITDA 19.9
JCI Per share dataJCI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates JCI does not grow enough to justify the current Price/Earnings ratio.
JCI has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)3409.63
PEG (5Y)2.15
EPS Next 2Y7.94%
EPS Next 3Y10.61%

7

5. Dividend

5.1 Amount

JCI has a Yearly Dividend Yield of 1.39%.
JCI's Dividend Yield is rather good when compared to the industry average which is at 1.15. JCI pays more dividend than 82.93% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.40, JCI's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.39%

5.2 History

The dividend of JCI is nicely growing with an annual growth rate of 6.63%!
JCI has paid a dividend for at least 10 years, which is a reliable track record.
As JCI did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)6.63%
Div Incr Years4
Div Non Decr Years7
JCI Yearly Dividends per shareJCI Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

JCI pays out 39.36% of its income as dividend. This is a sustainable payout ratio.
JCI's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP39.36%
EPS Next 2Y7.94%
EPS Next 3Y10.61%
JCI Yearly Income VS Free CF VS DividendJCI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B
JCI Dividend Payout.JCI Dividend Payout, showing the Payout Ratio.JCI Dividend Payout.PayoutRetained Earnings

JOHNSON CONTROLS INTERNATION

NYSE:JCI (8/4/2025, 8:17:05 PM)

After market: 106.48 0 (0%)

106.48

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)07-29 2025-07-29/bmo
Earnings (Next)N/A N/A
Inst Owners92.73%
Inst Owner Change0.46%
Ins Owners0.24%
Ins Owner Change-4.52%
Market Cap70.07B
Analysts74.07
Price Target110.41 (3.69%)
Short Float %1.34%
Short Ratio1.97
Dividend
Industry RankSector Rank
Dividend Yield 1.39%
Yearly Dividend1.49
Dividend Growth(5Y)6.63%
DP39.36%
Div Incr Years4
Div Non Decr Years7
Ex-Date06-23 2025-06-23 (0.37)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.4%
Min EPS beat(2)3.16%
Max EPS beat(2)7.63%
EPS beat(4)4
Avg EPS beat(4)5.16%
Min EPS beat(4)3.16%
Max EPS beat(4)7.63%
EPS beat(8)5
Avg EPS beat(8)2.05%
EPS beat(12)6
Avg EPS beat(12)1.3%
EPS beat(16)7
Avg EPS beat(16)0.84%
Revenue beat(2)1
Avg Revenue beat(2)0.66%
Min Revenue beat(2)-0.26%
Max Revenue beat(2)1.59%
Revenue beat(4)2
Avg Revenue beat(4)0.25%
Min Revenue beat(4)-2.38%
Max Revenue beat(4)2.04%
Revenue beat(8)2
Avg Revenue beat(8)-0.9%
Revenue beat(12)3
Avg Revenue beat(12)-1.15%
Revenue beat(16)5
Avg Revenue beat(16)-1%
PT rev (1m)4.45%
PT rev (3m)19.66%
EPS NQ rev (1m)0.68%
EPS NQ rev (3m)0.59%
EPS NY rev (1m)0.13%
EPS NY rev (3m)2.07%
Revenue NQ rev (1m)0.7%
Revenue NQ rev (3m)1.28%
Revenue NY rev (1m)-0.79%
Revenue NY rev (3m)0.57%
Valuation
Industry RankSector Rank
PE 28.09
Fwd PE 24.63
P/S 3.3
P/FCF 24.07
P/OCF 20.67
P/B 4.43
P/tB N/A
EV/EBITDA 19.9
EPS(TTM)3.79
EY3.56%
EPS(NY)4.32
Fwd EY4.06%
FCF(TTM)4.42
FCFY4.15%
OCF(TTM)5.15
OCFY4.84%
SpS32.31
BVpS24.02
TBVpS-6.97
PEG (NY)3409.63
PEG (5Y)2.15
Profitability
Industry RankSector Rank
ROA 5.91%
ROE 15.85%
ROCE 10.4%
ROIC 7.89%
ROICexc 8.09%
ROICexgc 23.62%
OM 14.94%
PM (TTM) 11.78%
GM 37.15%
FCFM 13.69%
ROA(3y)4%
ROA(5y)3.49%
ROE(3y)10.39%
ROE(5y)8.82%
ROIC(3y)6.34%
ROIC(5y)6%
ROICexc(3y)6.58%
ROICexc(5y)6.25%
ROICexgc(3y)23.86%
ROICexgc(5y)23.9%
ROCE(3y)8.19%
ROCE(5y)7.69%
ROICexcg growth 3Y-13.87%
ROICexcg growth 5Y1.5%
ROICexc growth 3Y-4.43%
ROICexc growth 5Y10.29%
OM growth 3Y-3.83%
OM growth 5Y11.73%
PM growth 3Y2.41%
PM growth 5Y-20.69%
GM growth 3Y1.1%
GM growth 5Y1.86%
F-Score7
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF 3.43
Debt/EBITDA 2.41
Cap/Depr 64.38%
Cap/Sales 2.25%
Interest Coverage 250
Cash Conversion 86.48%
Profit Quality 116.21%
Current Ratio 0.96
Quick Ratio 0.81
Altman-Z 2.34
F-Score7
WACC7.08%
ROIC/WACC1.11
Cap/Depr(3y)65.14%
Cap/Depr(5y)62.93%
Cap/Sales(3y)2.17%
Cap/Sales(5y)2.16%
Profit Quality(3y)91.89%
Profit Quality(5y)135.07%
High Growth Momentum
Growth
EPS 1Y (TTM)8.91%
EPS 3Y11.73%
EPS 5Y13.04%
EPS Q2Q%-7.89%
EPS Next Y0.01%
EPS Next 2Y7.94%
EPS Next 3Y10.61%
EPS Next 5Y11.04%
Revenue 1Y (TTM)-14.34%
Revenue growth 3Y-1.02%
Revenue growth 5Y-0.86%
Sales Q2Q%-16.3%
Revenue Next Year-11.84%
Revenue Next 2Y-3.8%
Revenue Next 3Y-1.07%
Revenue Next 5Y2.66%
EBIT growth 1Y57.46%
EBIT growth 3Y-4.81%
EBIT growth 5Y10.77%
EBIT Next Year14%
EBIT Next 3Y11.58%
EBIT Next 5Y9.3%
FCF growth 1Y165.36%
FCF growth 3Y-6.18%
FCF growth 5Y20.42%
OCF growth 1Y101.31%
OCF growth 3Y-5.6%
OCF growth 5Y11.44%